AKT1 and prostate cancer: These studies claim that growth factors such as EGF and bFGF induce EMT in prostate cancer cells via PKC and Akt-mediated inhibition of GSK3β, respectively [51, 52] showing increased phosphorylation of its Serine 9 residue upon EGF or bFGF stimulation.